RAS screening in colorectal cancer: a comprehensive analysis of the results from the UK NEQAS colorectal cancer external quality assurance schemes (2009–2016)

Evidence strongly indicates that extended RAS testing should be undertaken in mCRC patients, prior to prescribing anti-EGFR therapies. With more laboratories implementing testing, the requirement for External Quality Assurance schemes increases, thus ensuring high standards of molecular analysis. Da...

Descripción completa

Detalles Bibliográficos
Autores principales: Richman, Susan D., Fairley, Jennifer, Butler, Rachel, Deans, Zandra C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711992/
https://www.ncbi.nlm.nih.gov/pubmed/28653203
http://dx.doi.org/10.1007/s00428-017-2162-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711992/
https://www.ncbi.nlm.nih.gov/pubmed/28653203
http://dx.doi.org/10.1007/s00428-017-2162-7

Ejemplares similares